Physician profile
Paul Gardner
NPI 1407936271
$27,201.92
in general payments reported to CMS, 2019-2025
11 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,755 · 2020: $307 · 2021: $1,500 · 2022: $5,084 · 2023: $870 · 2024: $14K · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $2,062 · Food and Beverage: $1,475 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,000.00 |
| Travel and Lodging | $2,062.25 |
| Food and Beverage | $1,474.86 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $14,800.78 | 2019-2024 | Core, Sonopet Iq, Scopis Ent |
| Carl Zeiss Meditec, INC. | $5,061.34 | 2019-2021 | |
| Medexus Pharma, INC. | $4,289.67 | 2022 | |
| Medtronic, INC. | $1,561.55 | 2024-2025 | Mazor X System, Propel, Stealth Autoguide System |
| Karl Storz Endoscopy-America | $887.06 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $246.26 | 2019-2022 | |
| Microvention, INC. | $150.00 | 2019 | |
| Longeviti Neuro Solutions INC | $101.93 | 2025 | Clearfit |
| Integra Lifesciences Corporation | $83.33 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Csl Behring | $20.00 | 2023 | Kcentra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.